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Abstract
Pathologic data indicate that human cytomegalovirus
(HCMV) infection might be associated with the patho-
genesis of several human malignancies. However, no
definitive evidence of a causal link between HCMV
infection and cancer dissemination has been estab-
lished to date. This study describes the modulation of
the invasive behavior of NCAM-expressing tumor cell
lines by HCMV. Neuroblastoma (NB) cells, persistently
infected with the HCMV strain AD169 (UKF-NB-4AD169
and MHH-NB-11AD169), were added to endothelial cell
monolayers and adhesion and penetration kinetics
were measured. The 140- and 180-kDa isoforms of the
adhesion receptor NCAM were evaluated by flow
cytometry, Western blot, and reverse transcription–
polymerase chain reaction (RT-PCR). The relevance of
NCAM for tumor cell binding was proven by treating
NB with NCAM antisense oligonucleotides or NCAM
transfection. HCMV infection profoundly increased the
number of adherent and penetrated NB, compared to
controls. Surface expression of NCAM was signifi-
cantly lower on UKF-NB-4AD169 and MHH-NB-11AD169,
compared to mock-infected cells. Western-blot and
RT-PCR demonstrated reduced protein and RNA levels
of the 140- and 180-kDa isoform. An inverse correlation
between NCAM expression and adhesion capacity of
NB has been shown by antisense and transfection
experiments. We conclude that HCMV infection leads
to downregulation of NCAM receptors, which is
associated with enhanced tumor cell invasiveness.
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Introduction
Human cytomegalovirus (HCMV) is a b-herpes virus that
persistently infects 50% to 90% of the adult population.
Pathologic studies indicate that HCMV infection might be
associated with the pathogenesis of several human malig-
nancies. HCMV nucleic acids and proteins are present in
a high percentage of low- and high-grade malignant gliomas,
and expression of early and delayed HCMV gene products
occurs in these tumors [1]. Recently, significant amounts of
HCMV proteins and nucleic acids have been detected in
prostate carcinoma lesions [2], and also found to be localized
specifically in neoplastic cells in human colorectal polyps and
adenocarcinomas [3].
The oncogenic potential of HCMV is well established in vitro.
HCMV inhibits apoptosis [4], induces malignant transformation,
and dysregulates key cellular pathways involved in mutagen-
esis, angiogenesis [5], and evasion of immune recognition [6].
However, although the abovementioned studies indicate
that HCMV could facilitate tumor progression, there is still no
definitive evidence of a causal link between HCMV infection
and human cancer. One reason for this lack of evidence may
be due to the limited availability of adequate cell culture
models. HCMV-specific components are not detectable after
long-term subcultures of tumor tissues [7]. Moreover, the
presence of HCMV genetic information in human tumors is
difficult to interpret because HCMV can infect these organs
latently in a high percentage of normal individuals [8]. It also
remains possible that HCMV modulates the biologic prop-
erties of malignant cells without being directly involved in
carcinogenesis.
To elucidate the role of HCMV in tumor pathology in vitro,
long-term infection was mimicked using persistently infected
tumor cell lines [9]. Furthermore, we established an in vitro
assay, which allows the separate analysis of tumor cells that
adhere to an endothelial cell monolayer and those that trans-
migrate underneath the endothelium. We also considered
adhesion molecule expression because surface receptors are
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strongly implicated in tumor invasion. The neural cell adhe-
sion molecule (NCAM; CD56) was chosen to be the repre-
sentative molecule, as several data indicate that changes in
NCAM expression play an essential part in the progression
to tumor metastasis and that the modulation of NCAM is
one rate-limiting event in the metastatic dissemination of
tumor cells [10].
In the present study, NCAM-expressing neuroblastoma
(NB) cells were employed as the model tumor. The invasive
behavior of persistently infected NB cell lines has been
evaluated and compared to the invasive capacity of nonin-
fected variants. Analysis of the 140- and 180-kDa NCAM
isoforms was included in this study, as well. This is the first
report which demonstrates that HCMV directly contributes
to augmented tumor cell adhesion and transendothelial
penetration, and that this process is mediated through down-
regulation of NCAM.
Materials and Methods
Cell Cultures
Human umbilical vein endothelial cells (HUVECs) were
harvested by enzymatic treatment with chymotrypsin.
HUVECs were grown in Medium 199 (M199; Biozol, Munich,
Germany) and supplemented with 10% fetal calf serum
(FCS), 10% pooled human serum, 20 mg/ml endothelial cell
growth factor (Boehringer, Mannheim, Germany), 0.1% hep-
arin, 100 ng/ml gentamicin, and 20 mM Hepes buffer (pH
7.4). Subcultures from passages 2 to 4 were selected for
experimental use. The NB cell line UKF-NB-4 was estab-
lished from bone marrow metastasis of Evans stage 4 NB
[11]. The NB cell line MHH-NB-11 was purchased from
DSMZ (Braunschweig, Germany). NB cells were grown
and subcultured in Iscove’s modified Dulbecco’s medium
(IMDM; Seromed, Berlin, Germany) supplemented with 10%
FCS, 100 IU/ml penicillin, and 100 mg/ml streptomycin at
37jC in a humidified 5% CO2 incubator.
Establishment of Persistent HCMV Infection
HCMV laboratory strain AD169 was purchased from
ATCC (Rockville, MD). Virus stock was prepared in human
foreskin fibroblast (HFF) incubated in MEM, supplemented
with 4% FBS. Virus titer was determined by plaque titration
in HFF cells, as described previously [11]. NB cells were
infected with HCMV at a multiplicity of infection of 10. After
virus adsorption for 60 to 90 minutes at 37jC, cells were
incubated for 22 days and then split at a ratio of 1:5.
Subcultures were split at a ratio of 1:3 at 8-day intervals.
Cells were designated UKF-NB-4AD169 and MHH-NB-
11AD169. Immunoperoxidase staining against the HCMV-
specific immediate early protein (72-kDa immediate early
Ag IEA, UL123; DuPont, Bad Homburg, Germany) or the
nuclear late protein (67 kDa late Ag; LA; DuPont) was car-
ried out routinely after each subculture [12]. The efficiency of
HCMV infection was always about 30%, related to IEA-
expressing cells (see further details in Results section). For
control purposes, an irrelevant antibody directed against
HSV glycoprotein B was used. Mock-infected inocula were
prepared in an identical fashion, except that NB cells were
not infected with HCMV.
Monolayer Invasion Assay
Round cover slips were treated with 3-aminopropyl-trie-
thoxy-silan (2%; Sigma, Mu¨nchen, Germany)–acetone so-
lution for 60 minutes (20jC) to allow firm adhesion of
HUVECs and placed into six-well multiplates (Falcon
Primaria; Becton Dickinson, Heidelberg, Germany). HUVEC
subcultures were transferred to prepared multiplates in
complete HUVEC medium. When confluency was reached,
0.5  106 NB/well was carefully added to the HUVEC
monolayer for various time periods. Subsequently, nonad-
herent NB cells were washed off using warmed (37jC)
M199. The remaining cells were fixed with 1% glutar-
aldehyde. Bound NB cells were counted in five different
fields (5  0.25 mm2) using a phase-contrast microscope
( 20 objective) and the mean cellular adhesion rate was
calculated.
To separately assess NB cells that had penetrated the
HUVEC monolayer, a reflection interference contrast micro-
scope with a Ploem apparatus was used. The relevant theo-
retical evaluation of reflection contrast microscopy is given
by Bereiter-Hahn et al. [13] and Gingell and Todd [14]. The
resulting images were visualized and amplified by a Proxi-
tronic CCD camera (Proxitronic, Bensheim, Germany). The
number of penetrated NB was then quantified using the
image analyzing system ARGUS 20 (Hamamatsu, Hersching,
Germany). To optimize the signal-to-noise ratio, online back-
ground subtraction and averaging of eight images were
performed, using the image processing system QUANTI-
MET Q520 (Cambridge Instruments, Bensheim, Germany).
Cells that penetrated the HUVEC monolayer were counted
in five different fields (5  0.25 mm2,  20 objective), and
mean penetration rate was calculated as percentage of all
cells added.
Cell Proliferation
Proliferative activity of NB cells and HUVECs was esti-
mated by the PicoGreen (MoBiTec, Goettingen, Germany)
assay as described elsewhere [15]. Briefly, at several time
points after plating the cells in six-well multiplates, the culture
medium was removed and cells were digested with papain
(0.125 mg/ml protein) for 20 hours at 60jC. Thereafter, the
fluorescent dye PicoGreen, which shows high specificity
for dsDNA, was added (1:200 dilution) for 10 minutes at
20jC. Fluorescence intensity was determined using a com-
puter-controlled fluorescence reader (Cytofluor 2300 plate
scanner; Millipore, Eschborn, Germany) at kex = 485 nm and
kem = 530 nm.
Evaluation of NCAM Surface Expression
NB cells were disaggregated mechanically, washed in
blocking solution (phosphate-buffered saline [PBS], 0.5%
BSA), and then incubated for 60 minutes at 4jC with an
fluorescein isothiocyanate (FITC)–conjugated monoclonal
antibody anti- CD56, which detects the NCAM 140- and
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180-kDa isoform (clone ERIC-1). NCAM expression of NB
cells was then measured using a FACscan (FL-1H [log]
channel histogram analysis; 1  104 cells/scan; Becton
Dickinson) and expressed as relative fluorescence
units (RFU).
To determine if NCAM modulation was restricted to
HCMV-infected NB cells, NB cultures were double-stained
using an FITC-conjugated anti–CD56 monoclonal antibody
and the monoclonal antibody directed against the HCMV-
specific 72-kDa IEA, which was coupled to indocarbocya-
nine (Cy3; Dianova, Hamburg, Germany). At first, cells were
fixed with 100 ml of fixation medium (Fix and Perm; Biozol-
An der Grub Bioresearch, Eching, Germany) and washed
twice in blocking solution (PBS, 0.5% BSA). Subsequently,
they were incubated for 60 minutes at 4jC with 100 ml of
permeabilization medium (Fix and Perm) together with the
monoclonal antibody anti–72-kDa IEA. This process was
repeated to allow Cy3 labeling. In a further step, NB cells
were marked with the FITC-conjugated anti–CD56 mono-
clonal antibody. Dot plot quadrant analyses have been
carried out to display percentage distribution of NB-express-
ing Cy3-IEA and/or FITC-NCAM (IEA+/NCAM+, IEA+/
NCAM, IEA/NCAM+, IEA/NCAM). IEA and IEA+ cells
were gated to obtain two distinct cell populations: population
I (IEA+) as HCMV-infected cells and population II (IEA) as
noninfected NB cells. NCAM expression of both NB sub-
types was then detected by FACscan analysis (FL-1H [log]
channel histogram analysis; 1  104 cells/scan). A mouse
IgG1-FITC was used as an isotype control for CD56
mouse IgG1-FITC–conjugated antibody. To evaluate back-
ground staining of Cy3-conjugated anti–72-kDa IEA, goat
anti–mouse IgG Cy3 was used.
Western Blot Analysis
Total NCAM content in NB cells was evaluated by West-
ern blot analysis: NB lysates were applied to a 7% polyacryl-
amide gel and electrophoresed for 90 minutes at 60 V. The
protein was then transferred to nitrocellulose membranes.
After blocking, the membranes were incubated overnight
with the anti–NCAM antibody (dilution 1:1000). In additional
experiments, the AB-1 monoclonal antibody was used
(1:100; Calbiochem, Bad Soden, Germany) to detect
N-myc. p73 was measured using monoclonal anti-p73 (clone
ER-15, 1:500; Sigma). To identify DNp73, the monoclonal
antibody anti-DNp73 (clone 38C674, 1:500) was purchased
from Active Motif (Rixensart, Belgium). HRP-conjugated
goat anti–mouse IgG (dilution 1:5000; Upstate Biotechnolo-
gy, Lake Placid, NY) served as the secondary antibody. The
membrane was briefly incubated with ECL detection reagent
(ECL; Amersham, Freiburg, Germany) to visualize the pro-
teinsandexposed toanX-ray film (HyperfilmEC;Amersham).
Reverse Transcription–Polymerase Chain Reaction
(RT-PCR)
Total RNA was extracted and purified with Trizol reagent
according to the manufacturer’s instructions and treated with
RNase-freeDNase.TheNCAMprimersequenceswereas fol-
lows: forNCAM-180: 5V-CGAGGCTGCCTCCGTCAGCACC-
3 V and 5 V-CCGGATCCATCATGCTTTGCTCTCG-3 V;
for NCAM-140: 5V-GAACCTGATCAAGCAGGATGACGG-3V
and 5V-CCGGATCCATCATGCTTTGCTCTCG-3V. Internal
controls for the RT-PCR reaction were performed by
running parallel reaction mixtures with the housekeeping
gene GAPDH: 5V-ATCTTCCAGGAGCGAGATCC-3V and
5V-ACCACTGACACGTTGGCAGT-3V. RNA (1–10 mg) was
reverse-transcribed and the resulting cDNA was directly
added to the PCR. Amplification reactions (20 ml) were
performed in the presence of 1/10 (2 ml) of the cDNA reac-
tion, with an initial incubation step at 94jC for 1 minute.
Cycling conditions consisted of denaturation at 94jC for 1
minute, annealing at 55jC for 1 minute, and extension at
72jC for 1 minute over a total of 30 cycles. The reaction was
completed by another incubation step at 72jC for 10minutes.
The PCR products were subjected to electrophoresis in 2%
agarose gel and visualized by ethidium bromide.
Transfection Procedure
UKF-NB-4AD169 cells were transfected using the calcium
phosphate coprecipitation method with full-length cDNA,
encoding the human NCAM-140-kDa isoform inserted in
sense of the eukaryotic expression vector pHb-Apr-1-neo
[16]. Control cells were transfected with the expression vec-
tor alone. A total of 0.5  106 NB was seeded in 25-cm2
culture flasks, grown overnight, and transfected with 2 mg
of DNA. After culturing for 16 hours in complete medium,
cells were washed twice with PBS without Ca2+ and Mg2+
and then incubated with fresh cell culture medium. Twenty-
four hours after transfection, NCAM expression was assayed
by FACS analysis and adhesion experiments were carried
out. NB cell populations were not further sorted prior to the
assay. Efficiency of NCAM transfection using pHb-Apr1-neo
was investigated fluorometrically by calcium phosphate
coprecipitation of pHb-Apr1-neo in combination with
pEGFP-N1 vector (Clontech GmbH, Heidelberg, Germany)
at a ratio of 1:1. pEGFP-N1 encodes a red-shifted variant
of wild-type GFP, which has been optimized for brighter
fluorescence and higher expression in mammalian cells.
Fluorescence analysis revealed a transfection rate of
pHb-Apr1-neo of 30%. Viability of the cells, which was
controlled by trypan blue dye exclusion or quantitative fluo-
rescence analysis of propidium iodide uptake, was >90%.
Oligonucleotide Treatment of NB
In control studies, subconfluent parental UKF-NB-4 cells
were treated with NCAM antisense phosphorothioate oligo-
nucleotides and CG-matched randomized sequence phos-
phorothioate oligonucleotides, whose sequences are CAT
GGC TAC GCA CC (NCAM antisense) and ACC GAC CGA
CGT GT (random antisense). The antisense oligonucleoti-
des and controls were designed and manufactured by Biog-
nostic (Go¨ttingen, Germany). Cells were washed three times
in prewarmed PBS. A total of 100 mg/ml of oligonucleotides
was premixed for 10 minutes with 30 mg/ml DOTAP liposo-
mal transfection reagent (Boehringer) in 70 ml of Hepes buffer
(1:10 in PBS) and the desired concentration of 1 mg/ml was
applied to washed cells. NB cells were incubated with the
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oligonucleotides for 24 hours at 37jC, after which the
medium was removed and replaced with standard growth
medium for another 24 hours. To confirm that oligonucleo-
tides could penetrate NB cells, cells were treated with FITC-
labeled oligonucleotides, fixed after treatment with 0.5%
formaldehyde, and analyzed by fluorescence microscopy.
NCAM expression was measured by FACscan analysis. Cell
viability was examined as mentioned above.
Figure 1. Adhesion kinetics of UKF-NB-4AD169 (A) and MHH-NB-11AD169
(B) versus mock-infected controls. NB cells were added at a density of
0.5  106 cells/well to HUVEC monolayers for different time periods. Non-
adherent tumor cells were washed off in each sample, and the remaining
cells were fixed and counted in five different fields (50.25 mm2) using a
phase-contrast microscope. Adhesion capacity is depicted as tumor cell
binding and given in percentage of all cells added (mean ± SD; n = 5). X-axis
indicates the period of coculture.
Figure 2. Penetration kinetics of UKF-NB-4AD169 (A) and MHH-NB-11AD169
(B) versus mock-infected controls. NB cells were added at a density of
0.5  106 cells/well to HUVEC monolayers for different time periods. To
identify transmigrated NB from the cells which had bound to HUVEC, a
reflection interference contrast microscope with a Ploem apparatus was
used (see Materials and Methods section for details). Five different
observation fields (5  0.25 mm2) were chosen and mean penetration rate
was evaluated in each sample. Penetration rate is given as percentage of all
cells added (mean ± SD; n = 3). X-axis indicates the period of coculture.
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Statistics
All experiments were carried out at least three times.
Mean ± SD were calculated to produce the figures shown.
Statistical significance was determined by the Wilcoxon
signed rank test showing two-sided probabilities and using
normal approximation. Differences were considered statisti-
cally significant at a P value less than .05.
Results
Infiltration Kinetics of UKF-NB-4AD169 and MHH-NB-11AD169
Figure 1 shows the adhesion kinetics of UKF-NB-4AD169
(Figure 1A) and MHH-NB-11AD169 (Figure 1B ) versus mock-
infected cells. The number of adherent UKF-NB-4 cells
increased after 60 minutes (66.5±9.3 cells/mm2) and
Figure 3. Graph (A) shows adhesion kinetics of UKF-NB-4AD169 transfected
with 2 g of full-length cDNA encoding the human NCAM-140-kDa isoform.
Graph (B) demonstrates adhesion kinetics of parental UKF-NB-4 cells treated
with 1 g/ml NCAM antisense oligonucleotides. Control cells remained un-
treated or were either incubated with random antisense oligonucleotides or
transfected with the expression vector alone. In all experiments, NB cells were
added at a density of 0.5  106 cells/well to HUVEC monolayers. Non-
adherent tumor cells were washed off after different time periods, and the
remaining cells were fixed and counted in five different fields (5  0.25 mm2)
using a phase-contrast microscope. Data on NCAM surface expression,
evaluated by flow cytometry, are also given in the lower right-hand corner and
demonstrate the inverse correlation between NCAM expression level and
adhesion capacity. X-axis indicates the period of coculture (mean ± SD, n = 3).
Figure 4. NCAM surface expression on UKF-NB-4 (top) and MHH-NB-11
cells (bottom). Tumor cells were disaggregated mechanically and washed in
blocking solution. An FITC-conjugated monoclonal antibody anti-CD56, clone
ERIC-1, was used to detect the NCAM 140- and 180-kDa isoform. A mouse
IgG1-FITC served as the isotype control (IgG1). ‘‘AD169’’ depicts HCMV-
infected cells; ‘‘Mock’’ is related to mock infected controls. Fluorescence was
analyzed using a FACScan flow cytometer, and a histogram plot (FL1-Height)
was generated to show FITC fluorescence.
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reached a plateau after 4 hours (150.9 ± 24.3 cells/mm2).
HCMV infection led to considerable enhancement of the
adhesion process. The 60-minute adhesion values were
248.2 ± 51.5 cells/mm2. A total of 491.6 ± 68.7 cells/mm2
was adherent after 8 hours. The same was true for MHH-NB-
11 cells. HCMV infection elevated the amount of adherent
cells three-fold (60-minute values: MHH-NB-11: 9.3 ± 2.1
cells/mm2; MHH-NB-11AD169: 32.8 ± 2.7 cells/mm2; 8-hour
values: MHH-NB-11: 59.8 ± 10.6 cells/mm2; MHH-NB-
11AD169: 183.9 ± 23.8 cells/mm2). The same phenomenon
was observed with NB cells, which penetrated underneath
the HUVEC monolayer (Figure 2). The transmigration rates
of both UKF-NB-4AD169 (Figure 2A) and MHH-NB-11AD169
(Figure 2B ) were significantly upregulated, compared to
transmigration of mock-infected controls. The PicoGreen
assay, which had been carried out as well, revealed no
proliferative activity of NB cells during this time.
NCAM Is Relevant for NB Cell Adhesion
The relevance of NCAM for tumor cell binding to HUVECs
was demonstrated by transfection and antisense experi-
ments. Transfection of UKF-NB-4AD169 cells with NCAM
cDNA reverted the virus-evoked downregulating effect on
this receptor and resulted in a two-fold enhancement of
NCAM on the cellular membrane. Viability of UKF-NB-
4AD169 was not affected by this procedure. Adhesion of
transfected UKF-NB-4AD169 to HUVECs was strongly re-
duced (P < .05), compared to nontransfected cells (Figure
3A). Transfection of UKF-NB-4AD169 with a control plasmid
did not change NCAM expression or cell attachment.
Treatment of parental UKF-NB-4 cells with NCAM anti-
sense oligonucleotides diminished NCAM by 40% (viability
>90%) and significantly enhanced tumor cell adhesion to
HUVECs (Figure 3B). Control experiments using random
antisense treated NB showed no difference to untreated NB.
HCMV Infection Leads to Reduced NCAM Expression
Surface expression of NCAM on UKF-NB-4AD169 and
MHH-NB-11AD169 cells was strongly reduced compared to
the NCAM level on mock-infected cells. Mean values of five
experiments revealed 242.6 ± 49.2 RFU (UKF-NB-4Mock)
versus 101.9 ± 36.4 RFU (UKF-NB-4AD169), or 562.1 ± 73.5
Figure 5. Two-color fluorescence analysis of HCMV-infected UKF-NB-4 (A)
and MHH-NB-11 cells (B). At first, UKF-NB-4AD169 (Figure 4, top) or MHH-
NB-11AD169 cell cultures (Figure 4, bottom) were fixed and washed twice in
blocking solution. Subsequently, they were incubated for 60 minutes at 4jC
with permeabilization medium, together with the monoclonal antibody
directed against the HCMV-specific 72-kDa IEA (UL123), which was then
coupled to Cy3 indocarbocyanine. In the second step, NB cells were marked
with the FITC-conjugated anti –CD56 monoclonal antibody (see Materials
and Methods section for details). Dot plot quadrant analyses have been
carried out to display percentage distribution of NB-expressing Cy3-IEA and/
or FITC-NCAM (IEA+/NCAM+, IEA+/NCAM, IEA/NCAM+, IEA/NCAM—
upper diagram). IEA+ (R1) and IEA (R2) cells were gated (middle diagram)
to mark two distinct cell populations: population I (IEA+) as HCMV-infected
cells and population II (IEA) as noninfected NB cells. Mean fluorescence
intensity of NCAM expression of both NB subtypes was then detected by
FACscan analysis (FL-1H [log] channel histogram analysis; 530 nm peak
fluorescence [lower diagram]).
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RFU (MHH-NB-11Mock) versus 278.4 ± 54.3 RFU (MHH-NB-
11AD169). Figure 4 shows the histogram analysis of one
representative experiment.
Tumor cells can be subcultured continuously after initia-
tion of infection, without losing the virus. This long-term
persistence of virus in the tumor cell cultures is based on
the balance between CMV-infected and noninfected tumor
cells (i.e., between virus replication/release and prolifera-
tion of noninfected cells) [11]. To ensure that NCAM
reduction was specifically restricted to the subset of
HCMV-infected NB cells, a double-staining procedure
was performed. Analysis of HCMV-infected tumor cell
cultures demonstrated 30.92 ± 4.82% IEA+ MHH-NB-11
cells (mean ± SD, n = 3), or 32.03 ± 5.31% IEA+ UKF-NB-
4 cells (mean ± SD, n = 3). Separate evaluation of both
cell populations revealed that NCAM surface expression on
IEA+ cells is significantly lowered compared to the subset
of noninfected IEA cells. One representative experiment is
shown in Figure 5, A and B.
NCAM Loss Is Paralleled by N-myc Increase, DNp73
Increase, and p73 Reduction
Further experiments were carried out using MHH-NB-11
cells. Western blot data presented evidence that both
the NCAM 140- and 180-kDa proteins were reduced in
HCMV-infected cell cultures, compared to mock-infected
cells (Figure 6). Assessment of RNA expression of NCAM
showed downmodulation of mRNA encoding the 140- and
180-kDa isoform (Figure 7). To get more insights into HCMV-
triggered tumorigenesis and NCAM regulation, respectively,
the oncoprotein N-myc, the tumor-suppressor protein p73,
and the truncated p73 isoform DNp73 were analyzed as well.
Figure 6 demonstrates that both N-myc and DNp73 were
drastically upregulated, whereas p73 was strongly reduced
in HCMV-infected MHH-NB-11 cells compared to mock-
infected controls. The same results were obtained from
UKF-NB-4 versus UKF-NB-4AD169 cells (data not shown).
Discussion
Although there is evidence that infection with HCMV is
clinically associated with enhanced tumor metastasis and
progression, no clear data show that HCMV drives tumor
cell invasion. So far, disordered migration of virus-infected
neuronal cells has been observed in developing mouse
brains after infection with murine cytomegalovirus [17,18].
In another experimental model, HCMV infection of smooth
muscle cells (SMCs) has been linked to a significant
increase of SMC migration. This migration was inhibited
by the presence of anti–HCMV-neutralizing antibodies
[19,20]. Scholz et al. [21] reported that adhesion of
HCMV-infected NB cells, but not of noninfected control
cells, resulted in focal disruption of the integrity of HUVEC
monolayers, which then facilitated tumor cell transmigra-
tion. We present that HCMV directly contributes to aug-
mented NB cell adhesion and transendothelial penetration,
and that this process is mediated through downregulation
of NCAM on tumor cells.
Several studies demonstrate the important role of
NCAM in tumor migration and metastasis, with an inverse
relationship between migratory potential of the cells and
NCAM expression. In primitive neuroectodermal tumor
cells, an increase in NCAM was paralleled by a significant
reduction in cellular motility and adhesion capacity [22,23].
In a rat model, NCAM-transfected glioma tumor cells
became less invasive and destructive than control cells
Figure 6. Western blot analysis of NCAM, N-myc, p73, and DNp73 from the
proteins of MHH-NB-11 cells. MHH-NB-11 cells were either mock-infected or
permanently infected with HCMV strain AD169. Cell lysates were subjected to
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and
blotted on the membrane incubated with anti –NCAM (clone ERIC-1), anti –
N-myc (clone AB-1, anti –p73 (clone ER-15), or anti –DNp73 (clone 38C674)
monoclonal antibodies. -Actin served as the internal control. The figure
shows one representative from three separate experiments.
Figure 7. RT-PCR analysis of NCAM 140- and 180-kDa RNA in MHH-NB-
11AD169 cells (AD169) versus mock-infected controls (mock). RNA were
extracted, reverse-transcribed, and submitted to semiquantitative RT-PCR
using gene-specific primers as indicated in Materials and Methods section.
The figure shows one representative from three separate experiments.
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with a low NCAM expression level [24]. Diminished ex-
pression of NCAM was also associated with clinically
aggressive colon cancers [25–27], and dissemination of
pancreatic b tumor cells [28,29]. Tezel et al. [30] conclud-
ed from their studies that NCAM expression in tubular
adenocarcinoma of the pancreas has a significant impact
on overall patient survival. It is currently assumed that
NCAM, in its function as a homophilic receptor, stabilizes
the primary tumor or tumor cell aggregates while circulat-
ing in the blood vessels. Reduction of the NCAM expres-
sion level might lead to a reduction in cell–cell binding
forces, and hence to the release of tumors as single cells.
The less NCAM, the more putative metastatic cells leave
the tumor mass, and the more penetration events can
take place [10].
Our data reveal strong upregulation of the oncoprotein
N-myc in HCMV-infected cell cultures. Interestingly, NCAM
expression is closely correlated to the N-myc oncogene
level: transfection of the rat NB cell line B104 with an N-
myc expression vector resulted in a dramatic reduction in
the levels of NCAM polypeptides and mRNA and increased
metastatic ability. Spontaneous revertants of the high N-
myc phenotype were found to have regained significant
levels of NCAM expression, indicating that the continued
expression of N-myc is required to maintain the low NCAM
phenotype [31]. Subsequent experiments on human NB
cell lines have confirmed that N-myc regulates the expres-
sion of NCAM and that a reduced NCAM level is respon-
sible for the outcome of enhanced tumorigenic properties
[32,33]. In good accordance to our results, N-myc expres-
sion significantly increased in NB cells persistently infected
with HCMV [11]. These findings clearly corroborate our
hypothesis of HCMV-driven NCAM regulation and the
involvement of N-myc in this process.
Recently, a homologue of the tumor-suppressor p53,
termed p73, was described [34]. DNp73, an isoform of p73
lacking the N-terminal transactivation domain, was shown to
create a dominant-negative feedback loop that regulates p73
function. Melino et al. [35] proposed that dysregulation of p73
and enhanced expression of DNp73 forms are associated
with cancer development. Indeed, accumulation of DNp73
variants and loss of p73 full-length proteins have been found
in human neuroblastic tumors [36]. DNp73 expression sig-
nificantly correlated with poor overall and progression-free
survival [37]. Interestingly, in vitro experiments demonstrat-
ed that transfected full-length p73 cDNA induces expression
of NCAM and downregulation of N-myc in NB cells. Induction
of differentiation by retinoids in the same NB cells was
accompanied by accumulation of p73 and p73-regulated
transactivation of the NCAM promoter. Inversely, transfec-
tion of dominant-negative p73 in NB cells abrogated the
transactivation of the NCAM promoter induced by retinoids
[38]. Meanwhile, it has been discovered that the N-myc gene
directly modulates expression of p73/DNp73 and down-
stream elements [39].
The link between DNp73 gene products and viral infection
was established by Allart et al. [40]. They observed a robust
accumulation and stabilization of DNp73 in HCMV-infected
NB cells, which was accompanied by a higher tumorigenicity,
compared to mock-infected cells. Based on our in vitro
model, we present evidence that long-term HCMV infection
is accompanied by a loss of NCAM and p73, together with an
increase of N-myc and DNp73. We therefore postulate a
direct association between HCMV infection and tumor pro-
gression. HCMV shares the capacity of upregulating N-myc
and DNp73. Interference in the N-myc/DNp73 signalling
system causes, as at least one consequence, distinct down-
regulation of NCAM biosynthesis and receptor processing.
NCAM loss finally attributes to the enhanced invasive ca-
pacity of tumor cells (Figure 8). Further studies should
explore the effects of an antiviral therapy on tumor growth
and dissemination in vivo.
Figure 8. Schematic model of HCMV-triggered tumor dissemination. HCMV amplifies both N-myc and DNp73. Overexpression of the DNp73 isoform generates
a functional block of p73, with the net effect of NCAM downregulation. Loss of NCAM is strongly associated with enhanced tumor transmigration (see text for
further details).
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